Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
2,455
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Construction of a novel risk model based on the random forest algorithm to distinguish pancreatic cancers with different prognoses and immune microenvironment features

Yalan Leia Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Rong Tanga Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Jin Xua Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Bo Zhanga Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Jiang Liua Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Chen Lianga Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaORCID Iconhttps://orcid.org/0000-0003-0578-7589View further author information
ORCID Icon,
Qingcai Menga Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Jie Huaa Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Xianjun Yua Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaView further author information
,
Wei Wanga Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Si Shia Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China;c Shanghai Pancreatic Cancer Institute, Shanghai, China;d Pancreatic Cancer Institute, Fudan University, Shanghai, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6652-0629View further author information
ORCID Icon show all
Pages 3593-3602 | Received 27 Apr 2021, Accepted 26 Jun 2021, Published online: 09 Jul 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Kexin Jiang & Huawei Zou. (2022) microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1. Bioengineered 13:1, pages 917-929.
Read now
Jiarui Chen, Tuo Liang, Jiemei Cen, Jie Jiang, Shixin Pan, Shengsheng Huang, Liyi Chen, Xuhua Sun, Hao Li, Tianyou Chen, Wei Liang, Shian Liao, Chaojie Yu, Yuanlin Yao, Zhen Ye, Wuhua Chen, Hao Guo, Xinli Zhan & Chong Liu. (2021) A seven-gene signature and the C–C motif chemokine receptor family genes are the sarcoma-related immune genes. Bioengineered 12:1, pages 7616-7630.
Read now

Articles from other publishers (7)

Liuyan Su, Alphonse Houssou Hounye, Qi Pan, Kexin Miao, Jiaoju Wang, Muzhou Hou & Li Xiong. (2024) Explainable cancer factors discovery: Shapley additive explanation for machine learning models demonstrates the best practices in the case of pancreatic cancer. Pancreatology.
Crossref
Shensi Chen, Wujun Du, Ke Feng, Ke Liu, Cunji Li, Shengming Li & Hua Yin. (2024) AMIGO2 is a pivotal therapeutic target related to M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Aging 16:2, pages 1111-1127.
Crossref
Yongcheng Su, Fen Wang, Ziyu Lei, Jiangquan Li, Miaomiao Ma, Ying Yan, Wenqing Zhang, Xiaolei Chen, Beibei Xu & Tianhui Hu. (2023) An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic Cancer. International Journal of Molecular Sciences 25:1, pages 142.
Crossref
Baolin Qian, Qi Liu, Chaoqun Wang, Shounan Lu, Shanjia Ke, Bing Yin, Xinglong Li, Hongjun Yu, Yaohua Wu & Yong Ma. (2023) Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer. Scientific Reports 13:1.
Crossref
Yang Su, Ruoshan Qi, Lanying Li, Xu Wang, Sijin Li, Xuan Zhao, Rui Hou, Wen Ma, Dan Liu, Junnian Zheng & Ming Shi. (2022) An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Frontiers in Immunology 13.
Crossref
Shuhan Bu, Hien C. Nguyen, David C.R. Michels, Berk Rasheed, Sepideh Nikfarjam, Rohan Singh, Lynn Wang, Darshil A. Patel, Shweta Singh, Mohammad Qadura & Krishna K. Singh. (2022) Transcriptomics of angiotensin II-induced long noncoding and coding RNAs in endothelial cells. Journal of Hypertension 40:7, pages 1303-1313.
Crossref
Jinfeng Zhu, Qian Huang, Xingyu Peng, Chen Luo, Sicheng Liu, Zitao Liu, Xun Wu & Hongliang Luo. (2022) Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. Frontiers in Oncology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.